Table 2.

Susceptibility profile of isolated Escherichia coli and Klebsiella pneumoniae

Tested antibiotics	E. coli and K. pneumoniae		E. coli		K. pneumoniae
	Nb	Result	Nb	Result	Nb	Result
ESBL	1,827	104 (5.7%)	1,491	74 (5%)	336	30 (8.9%)
Penicillins
Amoxicillin	1,827	554 (30.3%)	1,491	554 (37.2%)	336	0 (0%)
Amoxicillin/clavulanic acid	1,827	1,450 (79.4%)	1,491	1,162 (77.9%)	336	288 (85.7%)
Piperacillin	1,827	555 (30.4%)	1,491	555 (37.2%)	336	0 (0%)
Piperacillin/Tazobactam	1,826	1,727 (94.6%)	1,490	1,421 (95.4%)	336	306 (91.1%)
Temocillin	1,138	1,117 (98.2%)	964	950 (98.5%)	174	167 (96%)
Mecillinam	1,042	961 (92.2%)	1,001	930 (92.9%)	41	31 (75.6%)
Cephalosporins
Cefotaxime	1,827	1,721 (94.2%)	1,491	1,415 (94.9%)	336	306 (91.1%)
Ceftazidime	1,827	1,733 (94.9%)	1,491	1,427 (95.7%)	336	306 (91.1%)
Cefepime	1,827	1,735 (95%)	1,491	1,427 (95.7%)	336	308 (91.7%)
Carbapenems
Imipenem	1,827	1,827 (100%)	1,491	1,491 (100%)	336	336 (100%)
Ertapenem	1,817	1,816 (99.9%)	1,487	1,487 (100%)	330	329 (99.7%)
Aminoglycosides
Amikacin	1,824	1,792 (98.2%)	1,489	1,466 (98.5%)	335	326 (97.3%)
Tobramycin	1,023	930 (90.9%)	839	766 (91.3%)	184	164 (89.1%)
Gentamycin	1,819	1,687 (92.7%)	1,483	1,373 (92.6%)	336	314 (93.5%)
Fluoroquinolones
Ofloxacin	1,827	1,467 (80.3%)	1,491	1,177 (78.9%)	336	290 (86.3%)
Ciprofloxacin	1,692	1,525 (90.1%)	1,368	1,232 (90.1%)	324	293 (90.4%)
Others
TMP/SMX	1,820	1,166 (64.1%)	1,486	886 (59.6%)	334	280 (83.8%)
Nitrofurantoin	1,819	1,671 (91.9%)	1,484	1,468 (98.9%)	335	203 (60.6%)
Fosfomycin	751	737 (98.1%)	711	705 (99.2%)	40	32 (80%)

Nb = number of tested isolates; TMP/SMX = trimethoprim/sulfamethoxazole.